Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampin-resistant Tuberculosis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Not applicableStudy completedNCT04208789
What this trial is testing

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Who this might be right for
MDR TuberculosisResistance to Tuberculostatic Drugs
Hasanuddin University 524
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Testing effectiveness (Phase 2)Looking for participantsNCT05555303
What this trial is testing

Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
Rwanda Biomedical Centre 20
Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Who this might be right for
Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
Huashan Hospital 120
Not applicableStudy completedNCT01587469
What this trial is testing

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Who this might be right for
Tuberculosis
Cepheid 992
Not applicableLooking for participantsNCT05073926
What this trial is testing

Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

Who this might be right for
Latent TuberculosisStaphylococcus Aureus
Region Skane 100
Not applicableUnknownNCT04545788
What this trial is testing

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Who this might be right for
Tuberculosis
Beijing Chest Hospital 200
Early research (Phase 1)Looking for participantsNCT05586230
What this trial is testing

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

Who this might be right for
TuberculosisRifampicin Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Large-scale testing (Phase 3)Active Not RecruitingNCT06081361
What this trial is testing

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Who this might be right for
Pulmonary TuberculosisRifampicin-resistant Tuberculosis
Beijing Chest Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT04568954
What this trial is testing

TB-CAPT CORE Truenat Trial

Who this might be right for
TuberculosisDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 3,987
Not applicableNot Yet RecruitingNCT06565806
What this trial is testing

French National Cohort of Patients With Rifampicin-Resistant Tuberculosis

Who this might be right for
Rifampicin-resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Load More Results